A Comparison of Budesonide and Mesalamine for Active Crohn's Disease
Data up to Jan 2025
Total Citations Per Year
Abstract
References (15)
Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study.
1976 • 3,140 citations
Development of a Crohn's Disease Activity Index
1976 • 3,024 citations
The Statistical Analysis of Failure Time Data
1982 • 2,300 citations
Hepatogastroenterology
2011 • 1,348 citations
National Cooperative Crohn's Disease Study: Results of drug treatment
1979 • 1,257 citations
The Psychological General Well-Being (PGWB) index
1984 • 694 citations
A Comparison of Budesonide with Prednisolone for Active Crohn's Disease
1994 • 601 citations
Oral Budesonide for Active Crohn's Disease
1994 • 569 citations
Mesalamine capsules for the treatment of active Crohn's disease: Results of a 16-week trial
1993 • 358 citations
Oral budesonide is as effective as oral prednisolone in active Crohn’s disease
1997 • 307 citations
Overview of Newer Glucocorticosteroid Preparations for Inflammatory Bowel Disease
1990 • 161 citations
5-Aminosalicylic Acid in the Treatment of Crohn's Disease: A 16-Week Double-Blind, Placebo-Controlled, Multicentre Study with Pentasa®
1987 • 132 citations
Slow-Release 5-Amino-Salicylic Acid (Pentasa®) for the Treatment of Active Crohn’s Disease
1990 • 79 citations
Oral 5-Aminosalicyclic Acid Versus 6-Methylprednisolone in Active Crohn's Disease
1990 • 25 citations
Medical Management of Crohn's Disease
2017 • 15 citations